Brazil’s antitrust authority CADE recommends a $1.2 billion penalty against Bayer and Monsanto for anticompetitive practices in the soy seed market, citing eight years of investigation into incentive programs for Intacta biotech adoption and the Monsoy Multiplica discount scheme. The case stems from CADE’s 2018 review of Bayer’s $63 billion Monsanto acquisition and targets conduct between 2018–2026. A final ruling by CADE’s tribunal is expected within 90 days. Bayer denies wrongdoing, asserting full compliance with Brazilian law.
According to www.cnnbrasil.com.br, Brazil’s Administrative Council for Economic Defense (CADE) has recommended imposing a fine of up to R$6.5 billion (approximately $1.2 billion USD) on Bayer and its subsidiary Monsanto for alleged anticompetitive conduct in the soybean seed and biotechnology licensing markets.
Investigation Origins and Timeline
The probe was initiated by CADE’s own Superintendence-General in January 2018, following complaints received during its review of Bayer’s $63 billion acquisition of Monsanto — finalized in June 2018. The investigation spanned over eight years, concluding with a technical report issued on 24 July 2026. During this period, CADE examined contracts, internal documents, economic and legal opinions, and submissions made during the merger approval process.
Key Alleged Conducts
CADE identified two primary practices that allegedly reinforced market dominance and restricted competition. First, Bayer and Monsanto implemented an incentive program targeting soybean breeders to adopt the proprietary Intacta RR2 Pro biotechnology — a genetically modified trait conferring resistance to certain lepidopteran pests and tolerance to glyphosate. According to CADE’s findings, these incentives discouraged development of conventional seeds or public-domain biotech alternatives.
The second practice involved the Monsoy Multiplica program, which offered non-linear discounts to seed multipliers based on volume thresholds. CADE determined that this structure created strong loyalty incentives toward Monsoy germplasm and Intacta technology, effectively raising barriers for rival seed companies seeking market access in Brazil — the world’s largest exporter of soybeans, accounting for over 50% of global exports.
Excluded Allegation and Legal Process
A third allegation — concerning contractual clauses requiring minimum purchases of parent seed from Bayer-Monsanto — was dismissed due to insufficient evidence. CADE concluded that no verifiable enforcement mechanism existed for this clause and recommended archiving that portion of the case. The remaining charges now move to CADE’s Administrative Tribunal for final adjudication, where commissioners will vote on whether to uphold the Superintendence’s recommendation for penalties and behavioral remedies.
Under Brazilian law, fines for antitrust violations can reach up to 20% of gross revenue generated in the relevant market during the prior fiscal year — a provision that underpins the proposed R$6.5 billion penalty. The tribunal’s decision is expected within 90 days of the formal submission of the case file.
Company Response and Industry Context
In its official statement, Bayer affirmed it had operated “
in strict compliance with applicable legislation
” and fully cooperated with CADE throughout the investigation, providing all requested clarifications. The company expressed confidence that the tribunal would confirm “
the absence of any anticompetitive infringement in its commercial practices
.”
This case follows broader regulatory scrutiny of agribusiness consolidation: Syngenta recently filed a patent infringement lawsuit against BASF in U.S. federal court, while BASF completed its acquisition of UK-based biologicals firm AgBiTech in September 2023. Meanwhile, CADE is concurrently reviewing allegations against nine other agtech firms, including a separate probe into 99Food launched after an urgent request from Keeta, a Brazilian food-tech startup.
Source: cnnbrasil.com.br
Compiled from international media by the SCI.AI editorial team.
